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DURING THE COURSE OF THE WORK of
the Cancer Research Campaign Bone
Tumour Panel (Sweetnam et al., 1971) a
large number of tumours in bone have
been studied histologically, with the
support of clinical and radiological infor-
mation. Included amongst the more than
1200 tumours are 11 chordomas. One of
these was a tumour from an unspecified
part of the skull and facial skeleton from
which a small but adequate biopsy sample
had been obtained in 1961. The histo-
logical appearances of this showed a
mixture ofchordoid and chondroid tissues.
Heffelfinger et al. (1973) had reported 22
cases of this type in 1973. Nevertheless
one of the difficulties in accepting the
reality of this state of affairs was uncer-
tainty over the criteria for recognizing the
two types of tissue, and the reliability
with which the distinction could be made.
This uncertainty led to the following
analytical study.
Each of the then 6 members of the
Panel examined in turn a collection of
sections stained with haematoxylin and
eosin, one from each of 29 cases (Table I).
The collection was known to contain
chondrosarcomas, chordomas and other
neoplasms, but no other information was
provided. The observers were asked to
indicate which of 4 diagnostic categories
they felt was most suitableforeachsection,
and to record the histological features used
to recognize chordoma and chondrosar-
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coma. The results were tabulated and
presented with the sections, but now only
of chordomas and chondrosarcomas, to
each of the observers (who then numbered
5) for review of their initial diagnoses and
criteria. The cases were then reviewed by
the Panel as a whole in the light of known
information about the problem.
Details of the 29 cases are shown in
Table I. There are 11 chordomas from
various levels of the spinal column; 2
sacral chondrosarcomas and 11 from
limbs; 4 undifferentiated malignant bone
tumours and 1 metastasis to bone. The
diagnoses of the selected cases had been
agreed by Panel members in previous
meetings, and formed the basis of the
classification in the Table.
The numbers of correct diagnoses on the
first and second readings are shown in
Table I. The number of observers on the
two occasions were different: 6 on the
first, and 5 on the second. On first reading
there were 12 cases in which all observers
were correct; in each of 5 additional cases
only one observer was wrong; 2 observers
were wrong in each of 4 cases, and more
than 2 in the remaining 8 cases. 4 of these
last 10 cases were chordomas and 6
chondrosarcomas.
The review of criteria after the first
reading led to a considerable improvement
on the second reading. This was expected,
since it had been evident that much of the
error in the first reading arose through theP. D. BYERS ET AL.
TABLE I.-A list of the cases used in the
preliminary study, with the number of
agreed diagnoses on two trials (see text)
Number agreed
Tumour
type
Chordoma
Chondro-
sarcoma
Malignant
unspecified
Code
No. Site (6
23 Skull base and
facial skeleton
26 unspecified
20 Skull base
9J
3 Cervical spine
6
10 Sacrum
18
28J
2 2 Sacrum
7
19
21 Femur-upper
25 end
27
29
11
12 Femur lower
17 end
22
14 Tibia-upper end
4
8
13
16
Secondary
carcinoma 24
1st
trial
6 obs.)
2
6
6
2
6
6
3
1
6
5
2
6
6
5
4
6
3
4
3
2
4
4
5
5
2nd
trial
(5 obs.)
1
5
5
4
5
5
5
5
5
5
2
5
5
5
5
5
5
5
5
4
5
5
5
5
6
6
5
6
6
misapplication of their own criteria by
several observers. Nevertheless there were
still 4 cases in which there were differences
of opinion, and merit comment. Three
were originally passed as chordomas: 1 of
these was the case at the root ofthe study
(Case 23), a lesion in the skull and facial
skeleton, the second was another skull
lesion (Case 9), and the third a sacral
lesion (Case 28). One peripheral chondro-
sarcoma caused difficulty (Case 11).
The tissue from the first (Case 23), from
the skull and facial skeleton, fulfilled the
criteria for cartilage, but did not meet
those for chordoma. Thus even though
there had been firm opinions that some of
the tissue belonged to the latter category
it could not be established by the critical
application of the criteria. As a result this
case was reclassified. The poorly differen-
tiated tissue of the second case (Case 9), a
skull lesion, caused difficulty. The third of
these cases, a rather mucinous tumour of
the sacrum, had been classed as a chor-
doma, apparently on the basis of columns
of cells in the mucinous matrix. But these
cells are spindle-shaped, and the pattern
was not ofthe kind seen in chordoma, but
that seen in the peripheral chondrosar-
comas. This case was also reclassified
as chondrosarcoma. The fourth case was
a peripheral chondrosarcoma and the
amount of disagreement between the
observers underlines the difficulty that
can be experienced with these classes of
tumour, and emphasizes the importance
of the knowledge of the site in reaching a
diagnosis.
It could be concluded that a high degree
of consistency on the part of several
observers in distinguishing between chor-
doma and chondrosarcoma could be
achieved.
It seemed desirable, however, to seek
to establish the most useful criteria for
achieving this result. In discussion it was
felt that there were 6 features most likely
to be important. These were:
1. Physaliphorous cells
2. Cells arranged in rows
3. Cells arranged in clusters
4. Mucinous material
5. Chondroid matrix
6. Calcified matrix
In order to get some idea of the value
of these features the number of cases was
increased to 23 chordomas and 28 chondro-
sarcomas. Three duplicate sections were
included in each class of tumour. In the
analysis these were treated as separate
cases, giving 26 chordoma and 31 chondro-
sarcoma sections. Included in the new
cases of chordoma were two of chondroid
type. By this time the Panel had been
increased to 9 members, and the sections
were presented blind to each member on
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TABLE II.-A summation of "present" (+) and "absent" (-) responses of each observer
compared with the others for eachfeature. The total number of comparisons for any one
feature was for chordomas, 936 and for chondrosarcomas, 1,116. But because "indeter-
minate" responses had been excluded the totals of comparisons vary; to make the results
more easily comparable the distribution of the compared responses has been converted to
percentage of row total. The column headed " + +" records agreement on thepresence of
thefeature; "- -" records agreement on its absence; "+ -" records disagreement
Responses
Definite
% Distribution Indeter-
Feature
Chondroid matrix
Cells in rows
Physaliphorous cells
Calcified matrix
Mucinous material
Cells in clusters
Tumour
Typet
CH
Cs
CH
Cs
CH
Cs
CH
Cs
CH
Cs
CH
CS
Number
800
1006
679
835
768
943
821
944
746
1004
662
826
t CH =chordoma; CS =chondrosarcoma.
one occasion who recorded for each slide
which of the 6 features was present, in-
determinate, or absent.
Observer agreement was assessed by the
Kappa statistic (Light, 1971).
The Kappa statistic is an analysis of
positive and negative observations using
a 2 x 2 table. If the response of each
observer to a single feature is compared
with the answer to the same question of
all the other observers there will be 36
comparisons. Thus for 26 chordoma sec-
tions this will give a total of 936 compari-
sons for each question. The total for
chondrosarcomas is l,116. These com-
parisons are most easily made in con-
tingency tables. Calculation of the Kappa
statistic uses only "yes" and "no" answers.
Thus the "indeterminate" answers must
be excluded from the calculations, and a
2 x 2 contingency table can be used. The
4 cells are + +, +-, -+, and --.
The difference between the totals recorded
in these 4 cells and the total possible com-
parisons, 936 for chordomas and i, l16
17
++
8
86
70
2
82
6
3
21
87
54
27
10
minate Kappa
+ - -- (% total) statistic
17 75 13 0-66
8 6 0-76
23 7 26 0-56
11 87 0-66
14 4 17 0-48
33 61 0 54
13 83 14 0 40
30 49 0 35
11 2 13 007
37 9 0-10
45 28 27 0-08
42 48 0-06
for chondrosarcomas, is a measure of the
observers' uncertainty in recognizing the
feature. Table II gives a summation of
positive and negative responses, and their
distribution between the three categories
of comparisons for definite responses
(+ +, + -/- +, - -) expressed as a
percentage of all definite responses for
the feature. Included in the table is also
the percentage of all responses that were
indeterminate.
For a feature to be useful it should have
a high total of definite responses, and the
positives and negatives should have high
but opposite values in the two tumours.
A statistical measure of this is given by
the Kappa statistic, also shown in Table
II. The Kappa statistic can be thought of
as a measure of agreement between
observers on a scale of 0 to 1. The higher
the value the greater the agreement.
What constitutes an acceptable level of
agreement is entirely arbitrary. But from
the data it is possible to put the features
in order of their value to the observers in
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this study for distinguishing between
chordoma and chondrosarcoma, viz.
Chondroid matrix
Cells in rows
Physaliphorous cells
Calcified matrix
Mucin
Cells in clusters
In Table III the mean value of the
summed responses (present=l, indeter-
minate= 2, absent= 3) in the second trial
(9 observers) to each of the 6 features for
TABLE III.-The mean responses by 9
observers for 6 features in the sections of
each type of tumour, for comparison with
the responses to two chondroid chordomas
Mean value
__________ Chondroid
Chord- Chondro- chordomas
oma sarcoma ,
26 31 No. No.
sections sections 1 2
Chondroid matrix 23 12 11 17
Cells in rows 14 24 24 12
Physaliphorous
cells 12 22 24 14
Calcified matrix 25 20 26 26
Mucinous material 11 14 14 10
Cells in clusters 18 21 24 14
all sections of chordoma and chondro-
sarcoma are listed, together with the
summed responses to the two chondroid
chordomas. Clearly these two tumours are
not identical and some features attract
more attention than others.
This study makes a comparative assess-
ment of the usefulness of the 6 features
regarded as most helpful by a number of
observers in differentiating between chor-
doma and chondrosarcoma. Three features
were of most use: chondroid matrix, cells
in rows andphysaliphorous cells. However,
it is evident from the scores for the two
chondroid chordomas that the evaluation
says little about their relative usefulness
in making a diagnosis. Nevertheless it
has been demonstrated that there are
features which can be defined and are
reasonably reliable for differentiating be-
tween the two types oftissue.
Material for this study was generously con-
tributed by Dr R. 0. Barnard, Maida Vale Hospital,
Dr M. H. Bennett, Mount Vernon Hospital, Pro-
fessor A. E. Claireaux, The Hospital for Sick
Children and Dr W. S. Killpack, King Edward
Memorial Hospital.
Advice on the statistical analysis was generously
given by Professor Mervyn Stone, Department of
Statistics, University College and by Dr A. M.
Skene of the same department, both of whose
analyses led to the one finally published.
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